These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 22231702

  • 1. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
    Rankin AL, Guay H, Herber D, Bertino SA, Duzanski TA, Carrier Y, Keegan S, Senices M, Stedman N, Ryan M, Bloom L, Medley Q, Collins M, Nickerson-Nutter C, Craft J, Young D, Dunussi-Joannopoulos K.
    J Immunol; 2012 Feb 15; 188(4):1656-67. PubMed ID: 22231702
    [Abstract] [Full Text] [Related]

  • 2. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity.
    Odegard JM, Marks BR, DiPlacido LD, Poholek AC, Kono DH, Dong C, Flavell RA, Craft J.
    J Exp Med; 2008 Nov 24; 205(12):2873-86. PubMed ID: 18981236
    [Abstract] [Full Text] [Related]

  • 3. IL-10 regulates murine lupus.
    Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J.
    J Immunol; 2002 Aug 15; 169(4):2148-55. PubMed ID: 12165544
    [Abstract] [Full Text] [Related]

  • 4. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 5. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 6. Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice.
    Fujii T, Okada M, Craft J.
    Cell Immunol; 2002 Oct 01; 217(1-2):23-35. PubMed ID: 12425998
    [Abstract] [Full Text] [Related]

  • 7. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS, Finck BK, Killeen N, Connolly MK, Goodman H, Wofsy D.
    Clin Immunol Immunopathol; 1998 Apr 01; 87(1):23-32. PubMed ID: 9576007
    [Abstract] [Full Text] [Related]

  • 8. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.
    Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K.
    J Immunol; 2007 Mar 15; 178(6):3822-30. PubMed ID: 17339481
    [Abstract] [Full Text] [Related]

  • 9. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT, Madaio MP, Shlomchik MJ.
    J Immunol; 1999 Oct 01; 163(7):3592-6. PubMed ID: 10490951
    [Abstract] [Full Text] [Related]

  • 10. Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model.
    Sharma J, Collins TD, Roach T, Mishra S, Lam BK, Mohamed ZS, Veal AE, Polk TB, Jones A, Cornaby C, Haider MI, Zeumer-Spataro L, Johnson HM, Morel LM, Larkin J.
    Sci Rep; 2021 Mar 18; 11(1):6354. PubMed ID: 33737712
    [Abstract] [Full Text] [Related]

  • 11. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O, Shlomchik MJ.
    J Immunol; 1998 Jan 01; 160(1):51-9. PubMed ID: 9551955
    [Abstract] [Full Text] [Related]

  • 12. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
    Santiago-Raber ML, Haraldsson MK, Theofilopoulos AN, Kono DH.
    J Immunol; 2007 Jun 15; 178(12):8195-202. PubMed ID: 17548658
    [Abstract] [Full Text] [Related]

  • 13. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y, Fujii T, Mimori T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H.
    J Immunol; 2014 Feb 01; 192(3):979-84. PubMed ID: 24391210
    [Abstract] [Full Text] [Related]

  • 14. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
    Liu L, Takeda K, Akkoyunlu M.
    Front Immunol; 2020 Feb 01; 11():1569. PubMed ID: 32849532
    [Abstract] [Full Text] [Related]

  • 15. T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice.
    Yang X, Yang J, Chu Y, Wang J, Guan M, Zhu X, Xue Y, Zou H.
    PLoS One; 2013 Feb 01; 8(4):e62855. PubMed ID: 23638156
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J, Li Q, Yang X, Li M.
    Mol Med; 2015 Apr 15; 21(1):364-70. PubMed ID: 25902303
    [Abstract] [Full Text] [Related]

  • 17. IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus.
    Dai H, He F, Tsokos GC, Kyttaris VC.
    J Immunol; 2017 Aug 01; 199(3):903-910. PubMed ID: 28646040
    [Abstract] [Full Text] [Related]

  • 18. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F, Li T, Zhang K, Wan J, Qi X.
    Int Immunopharmacol; 2016 Sep 01; 38():31-9. PubMed ID: 27235595
    [Abstract] [Full Text] [Related]

  • 19. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH, Tian L, Ling GS, Trendell-Smith NJ, Ma L, Lo CK, Stott DI, Liew FY, Huang FP.
    Eur J Immunol; 2008 Jun 01; 38(6):1664-76. PubMed ID: 18465774
    [Abstract] [Full Text] [Related]

  • 20. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.
    Mandik-Nayak L, Seo SJ, Sokol C, Potts KM, Bui A, Erikson J.
    J Exp Med; 1999 Jun 07; 189(11):1799-814. PubMed ID: 10359584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.